Analysts Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) PT at $18.23

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have received an average rating of “Hold” from the fifteen research firms that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, six have given a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $20.6923.

Several brokerages recently issued reports on ACHC. UBS Group upped their price objective on shares of Acadia Healthcare from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft decreased their price objective on Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating on the stock in a report on Wednesday, December 3rd. TD Cowen upped their target price on Acadia Healthcare from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Thursday. Royal Bank Of Canada increased their target price on Acadia Healthcare from $17.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Guggenheim lowered their price target on Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a report on Monday, February 23rd.

Hedge Funds Weigh In On Acadia Healthcare

A number of large investors have recently bought and sold shares of ACHC. Principal Financial Group Inc. raised its position in shares of Acadia Healthcare by 112.1% in the 3rd quarter. Principal Financial Group Inc. now owns 442,943 shares of the company’s stock worth $10,967,000 after buying an additional 234,107 shares during the period. Oppenheimer Asset Management Inc. grew its position in Acadia Healthcare by 85.1% during the second quarter. Oppenheimer Asset Management Inc. now owns 28,683 shares of the company’s stock valued at $651,000 after acquiring an additional 13,188 shares during the period. First Citizens Bank & Trust Co. increased its stake in Acadia Healthcare by 164.1% during the third quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company’s stock worth $1,464,000 after acquiring an additional 36,733 shares during the last quarter. Public Sector Pension Investment Board purchased a new position in shares of Acadia Healthcare in the 3rd quarter worth about $8,919,000. Finally, Caxton Associates LLP lifted its stake in shares of Acadia Healthcare by 1,234.5% in the 2nd quarter. Caxton Associates LLP now owns 173,482 shares of the company’s stock valued at $3,936,000 after purchasing an additional 160,482 shares in the last quarter.

Key Headlines Impacting Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Q4 revenue topped estimates and EPS beat consensus, driving a strong intraday jump; management provided FY2026 and Q1 2026 guidance that gave investors a clearer outlook. Acadia Healthcare’s (NASDAQ:ACHC) Q4 CY2025 Sales Top Estimates, Stock Jumps 10.8%
• Positive Sentiment: The company posted its Q4 earnings presentation and materials, helping investors parse revenue mix, margin drivers and the path to management’s FY26 targets. Acadia Healthcare Company, Inc. 2025 Q4 – Results – Earnings Call Presentation
• Positive Sentiment: Multiple brokerages raised price targets and maintain buy/outperform stances—RBC to $28 (outperform), UBS to $27 (buy) and TD Cowen to $24 (buy)—which increases buy-side conviction and likely supported the rally. Benzinga: Analyst Price-Target Updates
• Positive Sentiment: Analysts and commentary highlighted improving execution and embedded EBITDA opportunities under returning management, reinforcing the view that operational fixes could restore profitability. TipRanks: Buy Rating on Improving Execution
• Neutral Sentiment: Aggregated analyst coverage: a Benzinga deep-dive summarizes 17 analyst ratings and consensus perspectives — useful for context on how Street expectations are shifting but not a single catalyst. Acadia Healthcare Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
• Negative Sentiment: Short interest remains very large (~32.45M shares as of mid‑Feb, ~35.9% of float) with a ~7.3 days-to-cover ratio — this high short position increases the risk of volatile trading, squeezes, or pressure if execution disappoints. (short-interest reports summarized in filings and market data)

Acadia Healthcare Stock Up 5.2%

ACHC opened at $23.44 on Wednesday. The firm has a market cap of $2.16 billion, a P/E ratio of -1.92, a PEG ratio of 8.01 and a beta of 0.89. The business’s fifty day simple moving average is $14.82 and its 200 day simple moving average is $18.55. Acadia Healthcare has a 52 week low of $11.43 and a 52 week high of $33.58. The company has a quick ratio of 1.44, a current ratio of 1.55 and a debt-to-equity ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The firm had revenue of $821.46 million during the quarter, compared to the consensus estimate of $800.10 million. During the same quarter in the previous year, the company posted $0.64 EPS. The firm’s revenue for the quarter was up 6.1% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, equities research analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.